NEU 0.35% $20.17 neuren pharmaceuticals limited

this should be relevant to NEU's valuation, I would think...

  1. 12,999 Posts.
    lightbulb Created with Sketch. 774
    Just read the following article in today's paper:

    QUOTE

    Baxalta accepts US$ 32b bid from Shire

    Dublin-based pharmaceutical group Shire has agreed to buy US peer Baxalta for US$ 32 billion in a deal aimed at forming a global biotech giant targeting rare diseases. The agreed cash-and-share offer was an improvement on a previous hostile bid of US$ 3o billion that Baxalta rejected in August. The purchase of the Illinois-based group will boost Shire's position in the market for rare-disease treatments in the pharmaceutical sector, which is undergoing a rapid consolidation.
    "This proposed combination allows us to realise our vision of building the leading biotechnology company focused on rare diseases", Shire chief executive Flemming Ornskov said in a statement. "Our expanded portfolio and presence in more than 100 countries will drive our growth to over US$ 20 billion in anticipated annual revenues by 2020," he added.
    AFP

    END OF QUOTE

    Makes - JIMHO - for happy reading to any holder of NEU.

    wasa
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.17
Change
0.070(0.35%)
Mkt cap ! $2.578B
Open High Low Value Volume
$20.39 $20.53 $20.14 $4.102M 202.5K

Buyers (Bids)

No. Vol. Price($)
2 249 $20.15
 

Sellers (Offers)

Price($) Vol. No.
$20.31 790 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.